|
Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation
|
May 2015
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
|
How I Diagnose Low-Grade Myelodysplastic Syndromes
|
May 2020
|
American Journal of clinical Pathology
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management
|
Aug 2020
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
|
Nov 2020
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab
|
Aug 2020
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes
|
Nov 2019
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
|
Apr 2016
|
Anemia
|
myelodysplastic syndromes (MDS)
|
|
Spontaneous remision of aplastic anemia occurring during a pregnancy
|
Aug 2012
|
Ann Biol Clin (Paris)
|
aplastic anemia
|
|
Myelodysplastic syndromes: pathophysiology, clinical and biological features
|
Dec 2015
|
Ann Biol Clin (Paris)
|
myelodysplastic syndromes (MDS)
|
|
Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia
|
Dec 2014
|
Ann Hematol
|
aplastic anemia
|
